Clinical trials show new antibody therapy offers long-lasting HIV control without daily medication
If the past four decades have taught us anything about HIV, it's to adjust our expectations—despite enormous progress in ...
Gender-affirming care may reduce the risk of HIV among trans, nonbinary and gender-diverse people
Gender-affirming hormone therapy (GAHT) is associated with significantly improved HIV outcomes for transgender, nonbinary, ...